Matthew W. Foehr
President & CEO at OmniAb Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 2 boards, counting each seat separately. Longest: Viking Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
OmniAb Inc. June 17, 202698.0%
-
Viking Therapeutics Inc. May 20, 202563.4%
-
OmniAb Inc. June 23, 202399.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 7, 2026 | OmniAb Inc. | Option exercise | +36,459 | — | — |
| Apr 7, 2026 | OmniAb Inc. | Open-market sale | −19,244 | $1.49 | $28,674 |
| Feb 18, 2026 | OmniAb Inc. | Option exercise | +58,333 | — | — |
| Feb 18, 2026 | OmniAb Inc. | Open-market sale | −30,843 | $1.71 | $52,742 |
| Feb 17, 2026 | OmniAb Inc. | Open-market sale | −20,754 | $1.70 | $35,282 |
| Feb 16, 2026 | OmniAb Inc. | Option exercise | +36,458 | — | — |
| Jan 2, 2026 | Viking Therapeutics Inc. | Option exercise | +16,000 | $3.33 | $53,280 |
| Jan 2, 2026 | Viking Therapeutics Inc. | Open-market sale | −16,000 | $35.11 | $561,760 |
| Jan 2, 2026 | Viking Therapeutics Inc. | Grant or award | +3,150 | — | — |
| Dec 8, 2025 | OmniAb Inc. | Open-market sale | −13,666 | $1.96 | $26,785 |
| Dec 7, 2025 | OmniAb Inc. | Option exercise | +26,554 | — | — |
| Aug 26, 2025 | OmniAb Inc. | Grant or award | +540,540 | $1.85 | $999,999 |
| Apr 11, 2025 | Viking Therapeutics Inc. | Option exercise | +20,786 | $8.00 | $166,288 |
| Apr 7, 2025 | OmniAb Inc. | Option exercise | +36,458 | — | — |
| Apr 7, 2025 | OmniAb Inc. | Open-market sale | −19,382 | $2.00 | $38,764 |
Questions about Matthew W. Foehr
What boards is Matthew W. Foehr on?
Matthew W. Foehr sits on the boards of OmniAb Inc. and Viking Therapeutics Inc.
What company is Matthew W. Foehr the CEO of?
Matthew W. Foehr is President & CEO of OmniAb Inc.
How long has Matthew W. Foehr served on boards?
Our records show at least 8 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.